Factors influencing mortality in solid organ transplant recipients with bloodstream infection

Clinical Microbiology and Infection

Volumn 21, Issue 12, 2015, Pages 1104.e9-1104.e14

  Oriol, I ^a   Sabe N ^a   Melilli, E ^a   Llado L ^a   Gonzalez Costello J ^a   Soldevila, L ^a   Carratala J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Acute graft rejection; Antibiotic resistance; Bloodstream infection; Mortality; Septic shock; Solid organ transplantation

Indexed keywords

CARBAPENEM;

ACUTE GRAFT REJECTION; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BLOODSTREAM INFECTION; CONTROLLED STUDY; DEATH; FATALITY; FEMALE; GRAFT RECIPIENT; GRAM NEGATIVE BACTERIUM; HEART GRAFT; HUMAN; KIDNEY GRAFT; LIVER GRAFT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SHOCK; THROMBOCYTE COUNT; UNIVERSITY HOSPITAL; ADVERSE EFFECTS; BACTEREMIA; KIDNEY TRANSPLANTATION; MIDDLE AGED; ORGAN TRANSPLANTATION; PROSPECTIVE STUDY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TERTIARY CARE CENTER;

AGED; BACTEREMIA; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TERTIARY CARE CENTERS; TRANSPLANT RECIPIENTS;

EID: 84940866891     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2015.07.021     Document Type: Article

References (31)

1. Israni A.K., Zaun D.A., Rosendale J.D., Snyder J.J., Kasiske B.L. OPTN/SRTR 2011 Annual Data Report: deceased organ donation. Am J Transplant 2013, 13(Suppl. 1):179-198.
2. Fishman J.A. From the classic concepts to modern practice. Clin Microbiol Infect 2014, 20(Suppl. 7):4-9.
3. Dorschner P., McElroy L.M., Ison M.G. Nosocomial infections within the first month of solid organ transplantation. Transpl Infect Dis 2014, 16:171-187.
4. Moreno A., Cervera C., Gavaldá J., Rovira M., de la Cámara R., Jarque I., et al. Bloodstream infections among transplant recipients: results of a nationwide surveillance in Spain. Am J Transplant 2007, 7:2579-2586.
5. Koller M.T., van Delden C., Müller N.J., Baumann P., Lovis C., Marti H.-P., et al. Design and Methodology of the Swiss Transplant Cohort Study (STCS): a comprehensive prospective nationwide long-term follow-up cohort. Eur J Epidemiol 2013, 28:347-355.
6. Shi S.H., Kong H.S., Xu J., Zhang W.J., Jia C.K., Wang W.L., et al. Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients. Transpl Infect Dis 2009, 11:405-412.
7. Cervera C., van Delden C., Gavaldà J., Welte T., Akova M., Carratalà J. Multidrug-resistant bacteria in solid organ transplant recipients. Clin Microbiol Infect 2014, 20(Suppl. 7):49-73.
8. Al-Hasan M.N., Razonable R.R., Eckel-Passow J.E., Baddour L.M. Incidence rate and outcome of Gram-negative bloodstream infection in solid organ transplant recipients. Am J Transplant 2009, 9:835-843.
9. Bodro M., Sabé N., Tubau F., Lladó L., Baliellas C., Roca J., et al. Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients. Transplantation 2013, 96:843-849.
10. Magiorakos A.-P., Srinivasan A., Carey R.B., Carmeli Y., Falagas M.E., Giske C.G., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012, 18:268-281.
11. Friedman N.D., Kaye K.S., Stout J.E., McGarry S.A., Trivette S.L., Briggs J.P., et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002, 137:791-797.
12. Kim H.K., Park Y.K., Wang H.-J., Kim B.W., Shin S.Y., Lim S.-K., et al. Epidemiology and clinical features of post-transplant bloodstream infection: an analysis of 222 consecutive liver transplant recipients. Infect Chemother 2013, 45:315-324.
13. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013, 41:580-637.
14. Lumbreras C., Manuel O., Len O., ten Berge I.J.M., Sgarabotto D., Hirsch H.H. Cytomegalovirus infection in solid organ transplant recipients. Clin Microbiol Infect 2014, 20:19-26.
15. Gavaldà J., Meije Y., Fortún J., Roilides E., Saliba F., Lortholary O., et al. Invasive fungal infections in solid organ transplant recipients. Clin Microbiol Infect 2014, 20(Suppl. 7):27-48.
16. Kang C.-I., Kim S.-H., Park W.B., Lee K.-D., Kim H.-B., Kim E.-C., et al. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 2005, 49:760-766.
17. Gonçalves G.M., Zamboni D.S., Câmara N.O.S. The role of innate immunity in septic acute kidney injuries. Shock 2010, 34(Suppl. 1):22-26.
18. Suffredini A.F., Munford R.S. Novel therapies for septic shock over the past 4 decades. JAMA 2011, 306:194-199.
19. Paul M., Shani V., Muchtar E., Kariv G., Robenshtok E., Leibovici L. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother 2010, 54:4851-4863.
20. Ferrer R., Martin-Loeches I., Phillips G., Osborn T.M., Townsend S., Dellinger R.P., et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med 2014, 42:1749-1755.
21. Camargo L.F., Esteves A.B.A., Ulisses L.R.S., Rivelli G.G., Mazzali M. Urinary tract infection in renal transplant recipients: incidence, risk factors, and impact on graft function. Transplant Proc 2014, 46:1757-1759.
22. Gołebiewska J., Debska-Ślizień A., Komarnicka J., Samet A., Rutkowski B. Urinary tract infections in renal transplant recipients. Transplant Proc 2011, 43:2985-2990.
23. Neil D.A.H., Hübscher S.G. Current views on rejection pathology in liver transplantation. Transpl Int 2010, 23:971-983.
24. Lesurtel M., Raptis D.A., Melloul E., Schlegel A., Oberkofler C., El-Badry A.M., et al. Low platelet counts after liver transplantation predict early posttransplant survival: the 60-5 criterion. Liver Transpl 2014, 20:147-155.
25. Nijsten M.W., ten Duis H.J., Zijlstra J.G., Porte R.J., Zwaveling J.H., Paling J.C., et al. Blunted rise in platelet count in critically ill patients is associated with worse outcome. Crit Care Med 2000, 28:3843-3846.
26. Russwurm S., Vickers J., Meier-Hellmann A., Spangenberg P., Bredle D., Reinhart K., et al. Platelet and leukocyte activation correlate with the severity of septic organ dysfunction. Shock 2002, 17:263-268.
27. Wan Q.Q., Ye Q.F., Ming Y.Z., Ma Y., Zhou J.D., Qiao B.B. The risk factors for mortality in deceased donor liver transplant recipients with bloodstream infections. Transplant Proc 2013, 45:305-307.
28. Shao M., Wan Q., Xie W., Ye Q. Bloodstream infections among solid organ transplant recipients: epidemiology, microbiology, associated risk factors for morbility and mortality. Transplant Rev (Orlando) 2014, 28:176-181.
29. Silva M., Marra A.R., Pereira C.A.P., Medina-Pestana J.O., Camargo L.F.A. Bloodstream infection after kidney transplantation: epidemiology, microbiology, associated risk factors, and outcome. Transplantation 2010, 90:581-587.
30. Weinstein M.P., Towns M.L., Quartey S.M., Mirrett S., Reimer L.G., Parmigiani G., et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997, 24:584-602.
31. Kalil A.C., Syed A., Rupp M.E., Chambers H., Vargas L., Maskin A., et al. Is bacteremic sepsis associated with higher mortality in transplant recipients than in nontransplant patients? A matched case-control propensity-adjusted study. Clin Infect Dis 2015, 60:216-222.